Logo Logo

Publications by Ebert, M. P.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 1.

Journal article

Heinemann, V.; Ebert, M. P.; Laubender, Rüdiger P.; Bevan, P.; Mala, C.; Boeck, S. (2013): Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer. In: British Journal of Cancer BJC, Vol. 108, No. 4: pp. 766-770

This list was generated on Sun May 9 21:45:45 2021 CEST.